相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Limited clinical activity of nilotinib and sorafenib in FIP1L1-PDGFRA positive chronic eosinophilic leukemia with imatinib-resistant T674I mutation
G. Metzgeroth et al.
LEUKEMIA (2012)
Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome induce growth factor independence and leukemia-like disease
Christian Elling et al.
BLOOD (2011)
Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking
S. A. Walsh et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2011)
The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11)
Bartosz Wasag et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Eosinophils: multifaceted biological properties and roles in health and disease
Hirohito Kita
IMMUNOLOGICAL REVIEWS (2011)
Eosinophil extracellular DNA traps in skin diseases
Dagmar Simon et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Eosinophil and neutrophil extracellular DNA traps in human allergic asthmatic airways
Ryszard Dworski et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Developmental, Malignancy-Related, and Cross-Species Analysis of Eosinophil, Mast Cell, and Basophil Siglec-8 Expression
Sherry A. Hudson et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
Low-dose Nilotinib can maintain complete molecular remissions in FIP1L1/PDGFRA-positive hypereosinophilic syndrome
Emeline Tabouret et al.
LEUKEMIA RESEARCH (2011)
Eosinophil differentiation in the bone marrow is inhibited by T cell-derived IFN-γ
Alexander M. de Bruin et al.
BLOOD (2010)
Churg-Strauss syndrome: evidence for disease subtypes?
Christian Pagnoux et al.
CURRENT OPINION IN RHEUMATOLOGY (2010)
Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome
Florence Roufosse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Refining the definition of hypereosinophilic syndrome
Hans-Uwe Simon et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Practical approach to the patient with hypereosinophilia
Florence Roufosse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
What targeting eosinophils has taught us about their role in diseases
Bruce S. Bochner et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Human Airway Eosinophils Respond to Chemoattractants with Greater Eosinophil-Derived Neurotoxin Release, Adherence to Fibronectin, and Activation of the Ras-ERK Pathway When Compared with Blood Eosinophils
Mary Ellen Bates et al.
JOURNAL OF IMMUNOLOGY (2010)
A novel FIP1L1-PDGFRA mutant destabilizing the inactive conformation of the kinase domain in chronic eosinophilic leukemia/hypereosinophilic syndrome
S. Salemi et al.
ALLERGY (2009)
Hypereosinophilic Syndrome: Current Approach to Diagnosis and Treatment
Amy Klion
ANNUAL REVIEW OF MEDICINE (2009)
Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders
Peter Valent
BLOOD REVIEWS (2009)
Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors
B. S. Bochner
CLINICAL AND EXPERIMENTAL ALLERGY (2009)
Fluvastatin and lovastatin inhibit granulocyte macrophage-colony stimulating factor-stimulated human eosinophil adhesion to inter-cellular adhesion molecule-1 under flow conditions
A. J. Robinson et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2009)
Alemtuzumab Therapy for Hypereosinophilic Syndrome and Chronic Eosinophilic Leukemia
Srdan Verstovsek et al.
CLINICAL CANCER RESEARCH (2009)
Functional extracellular eosinophil granules: novel implications in eosinophil immunobiology
Josiane S. Neves et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Hypereosinophilic syndrome: A multicenter, retrospective analysis of clinical characteristics and response to therapy
Princess U. Ogbogu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1
Ayalew Tefferi
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially
Lisa A. Spencer et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Eosinophil-Selective Binding and Proapoptotic Effect in Vitro of a Synthetic Siglec-8 Ligand, Polymeric 6′-Sulfated Sialyl Lewis X
Sherry A. Hudson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
FIP1L1-PDGFRα D842V, a novel panresistant mutant, emerging after treatment of FIP1L1-PDGFRα T674I eosinophilic leukemia with single agent sorafenib
E. Lierman et al.
LEUKEMIA (2009)
Fibroblast growth factor receptor and platelet-derived growth factor receptor abnormalities in eosinophilic myeloproliferative disorders
Nicholas C. P. Cross et al.
ACTA HAEMATOLOGICA (2008)
Origin, regulation and physiological function of intestinal oeosinophils
Patricia C. Fulkerson et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2008)
Safety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome - a phase-II study
Georgia Metzgeroth et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Eosinophils: Biological properties and role in health and disease
Simon P. Hogan et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2008)
Dasatinib inhibits the growth and survival of neoplastic human eosinophils (EOL-1) through targeting of FIP1L1-PDGFRα
Christian Baumgartner et al.
EXPERIMENTAL HEMATOLOGY (2008)
Human eosinophils show chemotaxis to lymphoid chemokines and exhibit antigen-presenting-cell-like properties upon stimulation with IFN-gamma, IL-3 and GM-CSF
Yun-Jae Jung et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2008)
Sinus thrombosis in idiopathic hypereosinophilic syndrome causing fatal cerebral haemorrhage
Yoshihiro Numagami et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2008)
Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias
J. Gotlib et al.
LEUKEMIA (2008)
Improvement of cardiac function, mitral regurgitation and pulmonary hypertension in a patient with chronic eosinophilic leukemia (CEL) after low dose imatinib therapy
Maria-Theresa Krauth et al.
LEUKEMIA RESEARCH (2008)
Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense
Shida Yousefi et al.
NATURE MEDICINE (2008)
Treatment of patients with the hypereosinophilic syndrome with mepolizumab
Marc E. Rothenberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms
A. Tefferi et al.
LEUKEMIA (2008)
The diagnosis of BCR/ABL-negative chronic myeloproliferative diseases (CMPD): a comprehensive approach based on morphology, cytogenetics, and molecular markers
Torsten Haferlach et al.
ANNALS OF HEMATOLOGY (2008)
The severity of FIP1L1-PDGFRA-positive chronic eosinophilic leukaemia is associated with polymorphic variation at the IL5RA locus
S. Burgstaller et al.
LEUKEMIA (2007)
Activity of TK1258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome
Andrew Chase et al.
BLOOD (2007)
Novel approaches to therapy of hypereosinophilic syndromes
Hans-Uwe Simon et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2007)
Evaluation and differential diagnosis of marked, persistent eosinophilia
Thomas B. Nutman
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2007)
Cardiovascular manifestations of hypereosinophilic syndromes
Princess U. Ogbogu et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2007)
Chronic eosinophilic leukemias and the myeloproliferative variant of the hypereosinophilic syndrome
Barbara J. Bain et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2007)
Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders
Steven J. Ackerman et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2007)
Eosinophilic disorders
Dagmar Simon et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Inhibitory receptors on eosinophils: A direct hit to a possible Achilles heel?
Ariel Munitz et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia
Jelena V. Jovanovic et al.
BLOOD (2007)
Eosinophilia: A study of 100 hospitalized patients
Kobi Sade et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2007)
Diagnostic and therapeutic management of eosinophilia-associated chronic myeloproliferative disorders
Andreas Reiter et al.
HAEMATOLOGICA (2007)
A critical appraisal of conventional and investigational drug therapy in patients with hypereosinophilic syndrome and clonal eosinophilia
Matko Kalac et al.
CANCER (2007)
Eosinophilic granulocytes and damage-associated molecular pattern molecules (DAMPs) - Role in the inflammatory response within tumors
Ramin Lotfi et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Sorafenib is a potent inhibitor of HP1L1-PDGFRα and the imatinib-resistant FIP1L1-PDGFRα T674I mutant
Els Lierman et al.
BLOOD (2006)
Churg-Strauss Syndrome
KA Keogh et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Eosinophilia: secondary, clonal and idiopathic
A Tefferi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Approaches to the treatment of hypereosinophilic syndromes: A workshop summary report
Amy D. Klion et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Eosinophilic disorders: Molecular pathogenesis, new classification, and modern therapy
Jason Gotlib et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2006)
Chemotaxis of human peripheral blood eosinophils to 2-arachidonoylglycerol: Comparison with other eosinophil chemoattractants
Seishi Kishimoto et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2006)
The small molecule tyrosine kinase inhibitor AMN107 inhibits TEL-PDGFRβ and FIP1L1-PDGFRα in vitro and in vivo
EH Stover et al.
BLOOD (2005)
Hypereosinophilic syndrome: An update
HJ Wilkins et al.
AMERICAN JOURNAL OF HEMATOLOGY (2005)
Thrombotic microangiopathy associated with the hypereosinophilic syndrome
H Liapis et al.
KIDNEY INTERNATIONAL (2005)
Modern diagnosis and treatment of primary eosinophilia
A Tefferi
ACTA HAEMATOLOGICA (2005)
Interferon-gamma inhibits in vitro mobilization of eosinophils by interleukin-5
CS Park et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2005)
Expression and function of the vascular endothelial growth factor receptor FLT-1 in human eosinophils
C Feistritzer et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2004)
Eosinophilic myocarditis in a patient with idiopathic hypereosinophilic syndrome: Insights into mechanisms of myocardial cell death
D Corradi et al.
HUMAN PATHOLOGY (2004)
Anti-interieukin-5 (mepolizumab) therapy for hypereosinophilic syndromes
JK Garrett et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Eosinophilia in rheumatologic diseases: a prospective study of 1000 cases
AE Kargili et al.
RHEUMATOLOGY INTERNATIONAL (2004)
Expression and function of the angiopoietin receptor Tie-2 in human eosinophils
C Feistritzer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder
J Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Plasminogen activator inhibitor-2 (PAI-2) in eosinophilic leukocytes
JM Swartz et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
The role of human mast cell-derived cytokines in eosinophil biology
B Shakoory et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2004)
Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis
S Plotz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Expression and function of toll-like receptors in eosinophils: Activation by toll-like receptor 7 ligand
H Nagase et al.
JOURNAL OF IMMUNOLOGY (2003)
Changing expression of IL-3 and IL-5 receptors in cultured human eosinophils
C Yoshimura-Uchiyama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis
E Nutku et al.
BLOOD (2003)
Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders
A Pardanani et al.
BLOOD (2003)
PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative disease
J Cools et al.
CANCER CELL (2003)
A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome
J Cools et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy
A Pardanani et al.
BLOOD (2003)
Activation of the specific neurotrophin receptors TrkA, TrkB and TrkC influences the function of eosinophils
O Noga et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2002)
Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta
JF Apperley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Human eosinophils express two Siglec-8 splice variants
H Aizawa et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
Churg-Strauss syndrome: update on recent developments
WL Gross
CURRENT OPINION IN RHEUMATOLOGY (2002)
Mast cells, basophils, and eosinophils: distinct but overlapping pathways for recruitment
BS Bochner et al.
IMMUNOLOGICAL REVIEWS (2001)
Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration
JR White et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome
F Roufosse et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells, and basophils
KK Kikly et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2000)
Mechanisms of eosinophil-associated inflammation
GJ Gleich
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2000)
Inhibition of adhesion of human neutrophils and eosinophils to P-selectin by the sialyl Lewisx antagonist TBC1269:: Preferential activity against neutrophil adhesion in vitro
KL Davenpeck et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2000)
分享论文
